AppLovin Corporation engages in building a software-based platform for advertisers to enhance the marketing and monetization of their content in the United States and internationally. It operates through two segments, Advertising and Apps. The company's offers AppDiscovery, an advertising solution, which matches advertiser demand with publisher supply through auctions; MAX, an in-app bidding technology that optimizes the value of a publisher's advertising inventory by running a real-time competitive auction; Adjust, a measurement and analytics marketing platform that provides marketers with the visibility, insights, and data needed to scale their apps marketing; and Wurl, a connected TV platform, which distributes streaming video for content companies and provides advertising and publishing solutions through its AdPool, TVBits, BrandDiscovery, ContentDiscovery, and Global FAST Pass products. It also provides SparkLabs, which uses app store optimization to enhance ad visibility; AppLovin Exchange, which connects buyers to mobile and CTV devices through a single and direct RTB exchange; and Array, an end-to-end app management suite for mobile operators and end users. In addition, the company operates various free-to-play mobile games. It serves individuals, small and independent businesses, enterprises, advertisers and advertising networks, mobile app publishers, and indie studio developers. AppLovin Corporation was incorporated in 2011 and is headquartered in Palo Alto, California.

Applovin Corporation

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Appen (APPEF – Research Report) and Via Transportati...

Analysts Offer Insights on Technology Companies: Appen (OtherAPPEF) and Via Transportation, Inc. Class A (VIA)

Analysts have been eager to weigh in on the Communication Services sector with new ratings on AppLovin (APP – Research Report) and Genius Sports Li...

Analysts Offer Insights on Communication Services Companies: AppLovin (APP) and Genius Sports Limited (GENI)

Investors will find all of the hottest stock market news for Friday in our daily wrap-up.


Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Maxlinear (MXL – Research Report), Digital Turbine (...

Analysts Are Bullish on These Technology Stocks: Maxlinear (MXL), Digital Turbine (APPS)

Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on Cardlytics (CDLX – Research Report) an...

Analysts Have Conflicting Sentiments on These Communication Services Companies: Cardlytics (CDLX) and AppLovin (APP)

AppLovin ($APP) stock soared more than 2% on Monday after Needham upgraded its rating for the mobile ad tech platform to Buy from Hold with a price...

AppLovin Stock (APP) Rises as Needham Upgrades to ‘Buy’

Using the TipRanks Stock Screener Tool, we identified three companies with high price-to-earnings (P/E) ratios, Strong Buy consensus ratings, and m...

High P/E, High Hopes: 3 Stocks with Over 40% Upside in 2026

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Synopsys (SNPS – Research Report), AppFolio (APPF – ...

Analysts Are Bullish on These Technology Stocks: Synopsys (SNPS), AppFolio (APPF)

Appian ( ($APPN) ) has issued an announcement. On January 21, 2026, Appian announced that its Board of Directors had appointed David Link, co-found...

Appian Adds AI-Focused ScienceLogic CEO to Board

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rapport Therapeutics, Inc. (RAPP – Research Report),...

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Bausch + Lomb Corporation (BLCO)

Global Cannabis Applications Corp ( ($TSE:APP) ) has shared an announcement. Global Compliance Applications Corp. has moved to settle approximately...

Global Compliance Applications Converts $367,000 in Debt to Equity Units

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rapport Therapeutics, Inc. (RAPP – Research Report) and Moderna (...

Analysts Conflicted on These Healthcare Names: Rapport Therapeutics, Inc. (RAPP) and Moderna (MRNA)

Analysts are intrested in these 5 stocks: ( ($DIS) ), ( ($EPD) ), ( ($APP) ), ( ($RGTI) ) and ( ($QUBT) ). Here is a breakdown of their recent


Disney, EPD, AppLovin, Rigetti, QUBT Trending With Analysts

In a report released today, Raimo Lenschow from Barclays maintained a Sell rating on Appian, with a price target of $34.00. Lenschow covers the Tec...

Barclays Sticks to Their Sell Rating for Appian (APPN)

An update from Appen ( ($AU:APX) ) is now available. Appen Limited has announced the lapse of 4,023,781 performance rights, identified under ASX se...

Appen Performance Rights Lapse, Trimming Potential Equity Dilution

APAC Resources ( ($HK:1104) ) has provided an update. APAC Resources has alerted shareholders and investors that it expects to swing to a substanti...

APAC Resources Forecasts Up to HK$1.9 Billion Interim Profit on Resource Investment Rebound

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rapport Therapeutics, Inc. (RAPP – Research Report) ...

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Monte Rosa Therapeutics (GLUE)

Rapport Therapeutics, Inc. ( ($RAPP) ) just unveiled an update. On January 7, 2026, Rapport Therapeutics, Inc. filed a prospectus supplement to its...

Rapport Therapeutics Establishes $110 Million At-The-Market Offering

Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on Comcast (CMCSA – Research Report), Ame...

Analysts Have Conflicting Sentiments on These Communication Services Companies: Comcast (CMCSA), America Movil (AMX) and AppLovin (APP)

Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest profits drives continued...

3 “Strong Buy” Growth Stocks to Buy Now, According to Analysts – 1/6/2026

An update from Appen ( ($AU:APX) ) is now available. Appen Limited has announced that director Richard Freudenstein ceased to be a director of the ...

Current Quarter	$2.89	Next Quarter	$3.14
Current Year	$9.32	Next Year	$15.14
QoQ Growth	+8.7%	YoY Growth	+62.4%
3Y EPS CAGR	+2.6%	Target Price	$728.04
Consensus	Buy	Upside	+50.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	APP	$483.00	+2.09%	6.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	APP	$483.00	+2.1%	6.02M
3
4
5
6

APP

APP

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Applovin Corporation Data in Excel

Get Applovin Corporation Data in Excel